The Supreme Court is About to Stick it to Big Pharma

The Supreme Court is skeptical and that is never a good thing. During arguments Monday, several justices suggested drugmakers may be open to lawsuits over payments made to generic manufacturers that the Federal Trade Commission says are designed to forestall generic versions of drugs. The Washington Post reported that justices